Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F46ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,795
Award facts
- Contract value 100% obligated
- $47,794.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $47,794.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) with an ultimate completion date of January 27, 2026. This non-competitive, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
Erleada (abiraterone acetate) is a prescription medication primarily used in the treatment of advanced prostate cancer and is procured through DLA's pharmaceutical supply chain to support Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle, enabling the company to deliver a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to military healthcare programs worldwide. The DLA's Medical Supply Chain continues to leverage prime vendor agreements to ensure reliable access to critical pharmaceutical commodities for federal beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F46ZT?
SPE2DR26F46ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F46ZT worth?
The government has obligated $47,795 on SPE2DR26F46ZT.
Is contract SPE2DR26F46ZT an order under another contract?
Yes. SPE2DR26F46ZT is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46ZT competed?
The extent of competition for SPE2DR26F46ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award